Alpers Disease
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy (NCT04378075) | PTC Therapeutics | 2020-09-28 |
Track Alpers Disease automatically
Every clearance here is in the API, with alerts when new ones post.